Pyrazolopyrimidines and related heterocycles as kinase inhibitors
US8367681B2 · kind B2 · utility
3Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2010 |
| Grant date | Feb 5, 2013 |
| Priority date | — |
| Expiry date | Oct 4, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of general formula (I) that inhibit selected kinases (Pim and/or CK2 kinases) and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain infections and immunological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.